Resisting angiogenesis in hepatic fibrosis through the PDGFRB/ERK/HIF-1α and VEGFA/AKT/eNOS signaling pathways may serve as a promising therapeutic approach for treating hepatic fibrosis. Here, PDGFRB is linked to Hepatic fibrosis.